Clinical Trials Sponsored by Progenerative Medical, Inc

Total 2840 results

Progenerative Medical, Inc

Not yet recruiting

Regenn® Therapy System Safety Study

Surgical Wound

United States
Shire Regenerative Medicine, Inc.

Terminated

A Study of the Efficacy and Safety of ABH001 in the Treatment of Patients With Epidermolysis Bullosa Who Have Wounds That Are Not Healing

Epidermolysis Bullosa

United States, Spain, Austria, Canada, France, Germany, Poland, Portugal
Shire Regenerative Medicine, Inc.

Completed

Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers (LTFU)

Venous Leg Ulcer

United States, South Africa, Germany, Poland, Estonia, United Kingdom
Ankasa Regenerative Therapeutics, Inc.

Recruiting

Safety Evaluation of ART352-L in Subjects Undergoing Posterolateral Spinal Fusion

Degenerative Spondylolisthesis

United States
Healeon Medical Inc
Global Alliance for Regenerative Medicine

Suspended

Use of Stromal Vascular Fraction in Multiple Sclerosis (GARM-MS)

Multiple Sclerosis | Autoimmune

Honduras, United States
Healeon Medical Inc
Global Alliance for Regenerative Medicine

Withdrawn

Use of Cellular Stromal Vascular Fraction in Multiple Sclerosis,Autoimmune, Inflammatory, Neurologic Conditions (cSVF)

Multiple Sclerosis | Autoimmune

United States, Honduras
Harvard Apparatus Regenerative Technology, Inc.

Recruiting

Safety and Feasibility Study of the CELLSPAN Esophageal Implant (CEI) in Patients Requiring Short Segment Esophageal Replacement

Esophageal Diseases

United States
Medprin Regenerative Medical Technologies Co.,...

Unknown

Study to Evaluate the Safety and Efficacy of Dural Repair Patch in Neurosurgical Repairs

Neurosurgical Repairs

China
Medprin Regenerative Medical Technologies Co.,...

Unknown

Safety and Efficacy Study of Regen Sling to Treatment SUI

Stress Urinary Incontinence

China
Regeneris Medical
Global Alliance for Regenerative Medicine

Recruiting

Biocellular-Cellular Regenerative Treatment Scaring Alopecia and Alopecia Areata (SAAA)

Alopecia Areata | Scarring Alopecia

United States
jCyte, Inc
California Institute for Regenerative Medicine (CIRM)

Completed

Safety of Repeat Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With Retinitis Pigmentosa

Retinitis Pigmentosa

United States
Astellas Institute for Regenerative Medicine

Completed

Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)

Stargardt's Macular Dystrophy

United Kingdom
Astellas Institute for Regenerative Medicine

Completed

A Follow up Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)

Stargardt's Macular Dystrophy

United Kingdom
Astellas Institute for Regenerative Medicine

Completed

Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Patients With AMD

Age-Related Macular Degeneration

United States
Astellas Institute for Regenerative Medicine

Recruiting

A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

Age-Related Macular Degeneration

United States
Astellas Institute for Regenerative Medicine

Enrolling by invitation

A Safety Surveillance Study in Subjects With Macular Degenerative Disease Treated With Human Embryonic Stem Cell-derived Retinal Pigment Epithelial Cell Therapy

Macular Degenerative Disease

United Kingdom, United States
ExCellThera inc.
California Institute for Regenerative Medicine (CIRM)

Withdrawn

US Phase I Study of ECT-001-CB in Patients With Sickle-Cell Disease

Sickle Cell Disease | Umbilical Cord Blood | Hematopoietic Cell Proliferation

United States
jCyte, Inc
California Institute for Regenerative Medicine (CIRM)

Completed

Safety of a Single, Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Retinitis Pigmentosa

Retinitis Pigmentosa (RP)

United States
jCyte, Inc
California Institute for Regenerative Medicine (CIRM)

Completed

Safety and Efficacy of Intravitreal Injection of Human Retinal Progenitor Cells in Adults With Retinitis Pigmentosa

Retinitis Pigmentosa

United States
Astellas Institute for Regenerative Medicine

Completed

Safety and Tolerability of Sub-retinal Transplantation of hESC Derived RPE (MA09-hRPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration (Dry AMD)

Dry Age Related Macular Degeneration

United States
Astellas Institute for Regenerative Medicine

Completed

Sub-retinal Transplantation of hESC Derived RPE(MA09-hRPE)Cells in Patients With Stargardt's Macular Dystrophy

Stargardt's Macular Dystrophy

United States
Astellas Institute for Regenerative Medicine

Completed

Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Stargardt Macular Dystrophy Patients

Stargardt's Macular Dystrophy

United States
Astellas Institute for Regenerative Medicine

Withdrawn

Study to Evaluate Sub-retinal Transplantation of Retinal Pigmented Epithelial Cells in Patients With Dry AMD (PORTRAY)

Age-Related Macular Degeneration

United States
Regeneris Medical
Robert W. Alexander, MD, FICS; Global Alliance for Regenerative Medicine; Regeneris...

Unknown

Autologous Stem/Stromal Cells in Neurological Disorders and Disease (NDD)

Demyelinating Autoimmune Diseases, CNS | Dementia | Corticobasal Degeneration | Parkinson | Demyelinating Sensorimotor Neuropathy | Altered Behavior in Alzheimer Disease

United States
Poseida Therapeutics, Inc.
California Institute for Regenerative Medicine (CIRM)

Terminated

P-BCMA-101 Tscm CAR-T Cells in the Treatment of Patients With Multiple Myeloma (MM)

Multiple Myeloma

United States
Rocket Pharmaceuticals Inc.
California Institute for Regenerative Medicine (CIRM)

Completed

A Clinical Trial to Evaluate the Safety and Efficacy of RP-L201 in Subjects With Leukocyte Adhesion Deficiency-I

Leukocyte Adhesion Defect - Type I

Spain, United States, United Kingdom
Rocket Pharmaceuticals Inc.
California Institute for Regenerative Medicine (CIRM)

Terminated

A Trial to Evaluate Safety and Efficacy of RP-L401-0120 in Subjects With Infantile Malignant Osteopetrosis

Infantile Malignant Osteopetrosis

United States
Poseida Therapeutics, Inc.
California Institute for Regenerative Medicine (CIRM)

Active, not recruiting

Long-Term Follow-Up Study for Subjects Treated With P-BCMA-101

Multiple Myeloma

United States
Medeor Therapeutics, Inc.
California Institute for Regenerative Medicine (CIRM)

Active, not recruiting

Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants

Kidney Transplant Rejection

United States, Canada
Brain Neurotherapy Bio, Inc.
California Institute for Regenerative Medicine (CIRM); Asklepios Biopharmaceutical...

Active, not recruiting

GDNF Gene Therapy for Parkinson's Disease

Parkinson's Disease

United States
Lisata Therapeutics, Inc.
California Institute for Regenerative Medicine (CIRM); Sanford Health

Completed

Safety and Efficacy of CLBS03 in Adolescents With Recent Onset Type 1 Diabetes (The Sanford Project T-Rex Study)

Diabetes Mellitus

United States
Immune-Onc Therapeutics
California Institute for Regenerative Medicine (CIRM)

Recruiting

IO-202 as Monotherapy and IO-202 Plus Azacitidine ± Venetoclax in Patients in AML and CMML

CMML | AML With Monocytic Differentiation

United States
Cedars-Sinai Medical Center
California Institute for Regenerative Medicine (CIRM)

Recruiting

CNS10-NPC-GDNF Delivered to the Motor Cortex for ALS

Amyotrophic Lateral Sclerosis

United States
Cedars-Sinai Medical Center
California Institute for Regenerative Medicine (CIRM)

Recruiting

CNS10-NPC for the Treatment of RP

Retinitis Pigmentosa

United States
Cedars-Sinai Medical Center
California Institute for Regenerative Medicine (CIRM)

Completed

ALlogeneic Cardiosphere-derived Stem Cells (CDCs) for Pulmonary Hypertension therApy (ALPHA)

Pulmonary Arterial Hypertension (PAH)

United States
Cedars-Sinai Medical Center
California Institute for Regenerative Medicine (CIRM)

Completed

CNS10-NPC-GDNF for the Treatment of ALS

Amyotrophic Lateral Sclerosis

United States
Altamira Medica Ltd.

Completed

Efficacy and Safety of AM-301 on Allergic Symptoms of Perennial Allergic Rhinitis Sufferers

Rhinitis, Allergic | Perennial Allergic Rhinitis

Canada
NC Medial Research Inc

Recruiting

A Study of NCS-01 in Patients With Acute Ischemic Stroke

Ischemic Stroke

United States
CSA Medical, Inc.
Reset Medical, Inc.

Withdrawn

CryoSpray Ablation(tm)Thoracic Patient Registry

Asthma | Emphysema | Lung Cancer | Mesothelioma | COPD | Sarcoidosis | Chronic Bronchitis
Portland VA Medical Center
Center for Neuroscience and Regenerative Medicine (CNRM)

Recruiting

Improving Sleep, Sleep-related Outcomes, and Biomarkers in Veterans

Traumatic Brain Injury

United States
City of Hope Medical Center
California Institute for Regenerative Medicine (CIRM)

Active, not recruiting

A Blood Stem Cell Transplant for Sickle Cell Disease

Sickle Cell Disease | Anemia, Sickle Cell | Hemoglobinopathies | Thalassemia | Sickle Cell Disorder

United States
Robert W Alexander, MD
Regeneris Medical; Global Alliance for Regenerative Medicine

Unknown

Cellular & Biocellular Regenerative Therapy in Musculoskeletal Pain, Dysfunction,Degenerative or Inflammatory Disease (BRT)

Osteoarthritis | Back Pain | Tendinopathy | Tendinosis | Degenerative Joint Disease | Rheumatoid Nodule

United States
Broncus Medical Inc
Uptake Medical Technology, Inc.

Unknown

Post-Market Optimization Study of the EMPOWER® RF Catheter to Ablate Soft Tissue Lesions in the Lung

Lung Diseases

Germany
Broncus Medical Inc
Uptake Medical Technology, Inc.

Terminated

Feasibility Study of the RF Ablation Catheter to Ablate Lung Tumors

Lung Cancer | Lung Cancer Metastatic | Lung Cancer, Non-small Cell

China
Vivani Medical, Inc
Medpace, Inc.

Not yet recruiting

Assessment of Safety, Tolerability and Drug Levels of NPM-119 in Participants With Type 2 Diabetes (LIBERATE-1)

Type 2 Diabetes
Neovasc Inc.
Shockwave Medical, Inc.

Recruiting

Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II (COSIRA-II)

Refractory Angina

United States, Canada
Synchron Medical, Inc.

Withdrawn

SWITCH II Early Feasibility Study: Implantable BCI to Control a Digital Device for People With Paralysis

Paralysis | Amyotrophic Lateral Sclerosis | Muscular Dystrophies | Neurologic Disorder | Spinal Muscular Atrophy | Spinal Cord Injury | Stroke, Lacunar | Upper Limb Injury | Paralysis; Stroke | Stroke, Brainstem

Australia
Calibra Medical, Inc.
Medpace, Inc.

Completed

Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients

Diabetes Mellitus, Type 2

United States, France, United Kingdom, Germany
Synchron Medical, Inc.

Active, not recruiting

COMMAND Early Feasibility Study: Implantable BCI to Control a Digital Device for People With Paralysis

Paralysis | Amyotrophic Lateral Sclerosis | Muscular Dystrophies | Spinal Cord Injuries | Neurologic Disorder | Spinal Muscular Atrophy | Cervical Spinal Cord Injury | Stroke, Lacunar | Paralysis; Stroke | Stroke Brainstem | Tetraplegic; Paralysis | Quadriplegia/Tetraplegia

United States
Neovasc Inc.
Shockwave Medical, Inc.

Active, not recruiting

REDUCER-I: An Observational Study of the Neovasc Reducer™ System

Angina Pectoris | Chronic Stable Angina | Angina Pectoris, Stable

Netherlands, Spain, United Kingdom, Germany, Italy, Switzerland, Belgium, France, Austria

Clinical Trials Sponsored by Progenerative Medical, Inc

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Arab Emirates

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations